In a study involving clear cell renal cell carcinoma (ccRCC) by Li et al, researchers identified MCT1 as a significant facilitator of ccRCC, with its role in metabolic reprogramming mediated through acetate transport (54). This evidence concerns the gene SLC16A1 and nonpapillary renal cell carcinoma.